Product Details
| Product Name:
IDT307 |
CAS No.:
1141-41-9 |
| Supply Ability:
10g |
Release date:
2025/10/21 |
Product Introduction
Bioactivity
| Name | IDT307 |
| Description | IDT307 is a fluorescent analog of MPP+, a fluorescent substrate for DAT (fluorescent substrate APP+), and can be used for rapid identification and characterization of PMAT inhibitors. |
| Cell Research | 1. For PMAT inhibitor screening
1. Cell preparation: In cell culture, select a cell line suitable for the study, such as cells expressing PMAT.
2. Add IDT307: Add IDT307 to the cell culture medium, usually at a concentration of 1-50 μM.
3. Inhibitor treatment: Add a known PMAT inhibitor or potential inhibitor to the experiment, and detect fluorescence changes after a certain period of culture.
4. Fluorescence detection: Detect the fluorescence changes of IDT307 by fluorescence microscopy or fluorescence microplate reader (usually using Ex: 485 nm, Em: 535 nm wavelength). A decrease in fluorescence intensity usually means the inhibitory effect of PMAT.
2. For DAT substrate characterization
1. Cell preparation: Perform experiments in neuronal cell lines with DAT expression.
2. Add IDT307: Dissolve IDT307 in an appropriate buffer and add it to the cell culture medium.
3. Fluorescence detection: At appropriate time points, measure the fluorescence signal by fluorescence microscopy or spectrophotometer to observe DAT-mediated IDT307 transport.
III. Evaluation of dopamine transporter function
1. Cell preparation: Use cell lines with DAT expression, or extract neurons from mouse brain tissue for experiments.
2. Add IDT307: Add IDT307 to the culture medium and incubate the cells for a certain period of time.
3. Fluorescence detection: Use appropriate fluorescence detection equipment to monitor the changes in the fluorescence intensity of IDT307 and then evaluate the DAT function. |
| In vitro | IDT307 is an analog of the organic cation MPP+, which is transported to the parietal membrane (cerebrospinal fluid-facing side) of choroid plexus (CP) epithelial cells. Its transport process is highly sensitive to the PMAT inhibitor quinine. In Pmat knockout mice, uptake of IDT307 by choroid plexus tissue and its intracellular accumulation are significantly reduced by approximately 70%. [1] |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 50.00 mg/mL (146.97 mM), Sonication is recommended.
|
| Keywords | IDT-307 | IDT307 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$0.00/1KG |
VIP6Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2024-08-15 |
United States